small molecule

BAL

DIMERCAPROL

Loss of exclusivityloss of exclusivity
CompanyPROVEPHARM SAS

Drug detail

Brand nameBAL
Active ingredientDIMERCAPROL
Strength10%
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BAL patent cliff — loss of exclusivity — | CliffBio